Long-Term Treatment Goals

Enhancing Healthy Outcomes

Daniel Casey

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The long-term management of schizophrenia with a goal of functional rehabilitation remains an enormous challenge to clinicians despite improvements in drug therapy, psychosocial treatments, and family and community interventions. The goals of long-term therapy are to preserve the gains made during acute treatment, prevent symptom exacerbation, enhance psychosocial functioning, and improve quality of life. Schizophrenia is an illness that disrupts broad areas of mental function, including thought, cognition, affect, and motor performance. The new antipsychotics should aid physicians in meeting higher treatment goals for persons with schizophrenia. These agents combine high efficacy with improved tolerability, mainly through a low liability for extrapyramidal symptoms and probably improve cognitive affect. Recent studies have demonstrated efficacy of these new antipsychotics in improving psychopathology and symptoms and in preventing relapse during long-term use. These drugs are likely to provide physicians with an increasingly viable option in the long-term treatment and rehabilitation of patients with schizophrenia.

Original languageEnglish (US)
Pages (from-to)26-28
Number of pages3
JournalCNS Spectrums
Volume8
Issue number11 SUPPL. 2
StatePublished - Nov 2003

Fingerprint

Schizophrenia
Antipsychotic Agents
Rehabilitation
Physicians
Therapeutics
Psychopathology
Cognition
Quality of Life
Recurrence
Drug Therapy
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Cite this

Casey, D. (2003). Long-Term Treatment Goals: Enhancing Healthy Outcomes. CNS Spectrums, 8(11 SUPPL. 2), 26-28.

Long-Term Treatment Goals : Enhancing Healthy Outcomes. / Casey, Daniel.

In: CNS Spectrums, Vol. 8, No. 11 SUPPL. 2, 11.2003, p. 26-28.

Research output: Contribution to journalArticle

Casey, D 2003, 'Long-Term Treatment Goals: Enhancing Healthy Outcomes', CNS Spectrums, vol. 8, no. 11 SUPPL. 2, pp. 26-28.
Casey, Daniel. / Long-Term Treatment Goals : Enhancing Healthy Outcomes. In: CNS Spectrums. 2003 ; Vol. 8, No. 11 SUPPL. 2. pp. 26-28.
@article{00800ecf3e2d4a5c93f44e9f1fa228fb,
title = "Long-Term Treatment Goals: Enhancing Healthy Outcomes",
abstract = "The long-term management of schizophrenia with a goal of functional rehabilitation remains an enormous challenge to clinicians despite improvements in drug therapy, psychosocial treatments, and family and community interventions. The goals of long-term therapy are to preserve the gains made during acute treatment, prevent symptom exacerbation, enhance psychosocial functioning, and improve quality of life. Schizophrenia is an illness that disrupts broad areas of mental function, including thought, cognition, affect, and motor performance. The new antipsychotics should aid physicians in meeting higher treatment goals for persons with schizophrenia. These agents combine high efficacy with improved tolerability, mainly through a low liability for extrapyramidal symptoms and probably improve cognitive affect. Recent studies have demonstrated efficacy of these new antipsychotics in improving psychopathology and symptoms and in preventing relapse during long-term use. These drugs are likely to provide physicians with an increasingly viable option in the long-term treatment and rehabilitation of patients with schizophrenia.",
author = "Daniel Casey",
year = "2003",
month = "11",
language = "English (US)",
volume = "8",
pages = "26--28",
journal = "CNS Spectrums",
issn = "1092-8529",
publisher = "MBL Communications",
number = "11 SUPPL. 2",

}

TY - JOUR

T1 - Long-Term Treatment Goals

T2 - Enhancing Healthy Outcomes

AU - Casey, Daniel

PY - 2003/11

Y1 - 2003/11

N2 - The long-term management of schizophrenia with a goal of functional rehabilitation remains an enormous challenge to clinicians despite improvements in drug therapy, psychosocial treatments, and family and community interventions. The goals of long-term therapy are to preserve the gains made during acute treatment, prevent symptom exacerbation, enhance psychosocial functioning, and improve quality of life. Schizophrenia is an illness that disrupts broad areas of mental function, including thought, cognition, affect, and motor performance. The new antipsychotics should aid physicians in meeting higher treatment goals for persons with schizophrenia. These agents combine high efficacy with improved tolerability, mainly through a low liability for extrapyramidal symptoms and probably improve cognitive affect. Recent studies have demonstrated efficacy of these new antipsychotics in improving psychopathology and symptoms and in preventing relapse during long-term use. These drugs are likely to provide physicians with an increasingly viable option in the long-term treatment and rehabilitation of patients with schizophrenia.

AB - The long-term management of schizophrenia with a goal of functional rehabilitation remains an enormous challenge to clinicians despite improvements in drug therapy, psychosocial treatments, and family and community interventions. The goals of long-term therapy are to preserve the gains made during acute treatment, prevent symptom exacerbation, enhance psychosocial functioning, and improve quality of life. Schizophrenia is an illness that disrupts broad areas of mental function, including thought, cognition, affect, and motor performance. The new antipsychotics should aid physicians in meeting higher treatment goals for persons with schizophrenia. These agents combine high efficacy with improved tolerability, mainly through a low liability for extrapyramidal symptoms and probably improve cognitive affect. Recent studies have demonstrated efficacy of these new antipsychotics in improving psychopathology and symptoms and in preventing relapse during long-term use. These drugs are likely to provide physicians with an increasingly viable option in the long-term treatment and rehabilitation of patients with schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=1642542625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642542625&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 26

EP - 28

JO - CNS Spectrums

JF - CNS Spectrums

SN - 1092-8529

IS - 11 SUPPL. 2

ER -